Wealthedge Investment Advisors LLC Makes New Investment in Elevance Health, Inc. $ELV

NodeGuardian · 2026-03-08T03:48:06+00:00

Wealthedge Investment Advisors LLC acquired 8,439 shares of Elevance Health, increasing institutional ownership to 89.24%. Analysts favor a "Moderate Buy" rating, with a target of $390.55, as the company surpasses EPS expectations and boosts dividends.

NodeGuardian

2026-03-08 03:48:06

Abstract generation in progress

Wealthedge Investment Advisors LLC recently initiated a new position in Elevance Health, Inc. (NYSE:ELV) during Q3, purchasing 8,439 shares valued at approximately $2.73 million, contributing to a total institutional ownership of 89.24%. Analysts generally maintain a “Moderate Buy” consensus with an average price target of $390.55. Elevance Health has recently exceeded EPS expectations, increased its quarterly dividend, and trades with a market capitalization of roughly $70.8 billion.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.